Harnessing the power of the immune system to fight malignancies remains a significant challenge. European scientists produced different surfaces decorated with arrays of nanoparticles to generate an artificial ex vivo T cell activation platform.
Adoptive T cell therapy is a therapeutic intervention that entails the isolation and ex vivo expansion of patient autologous cancer-specific T cells. The approach has the potential to induce complete and durable regression of certain human malignancies, provided sufficient numbers of T cells can be obtained.
Further details: Nanotechnology aids cancer immunotherapy